Three proteins, protective antigen (PA), lethal factor (LF), and edema factor (EF; a calmodulin-dependent adenylate cyclase), compose the lethal (PA+LF) and edema (PA+EF) toxins secreted by Bacillus anthracis. Mutant strains, each deficient in the production of one toxin component, were constructed, and their virulence was then studied. A kanamycin resistance cassette was inserted in each cya (encoding EF) and lef(encoding LF) gene, and the constructs were separately introduced into B. anthracis Sterne on a mobilizable shuttle plasmid. An EF-strain and an LF-strain were then isolated after homologous recombination with the resident toxin-encoding plasmid, pXO1. Spores from these mutants and from a previously constructed PA-mutant were used to inoculate mice, and the lethality and local edema formation were monitored. LF-or PA-mutants were not lethal even at high inocula, whereas the EF-mutant induced lethal infections. This indicates that LF in combination with PA is a key virulence factor required for lethality. Skin edema formation was observed with the LF-mutant, which produces only the combination of PA and EF. However, EF-and LF-mutants were significantly less efficient at inducing, respectively, lethality and edema than was the parental Sterne strain. These results suggest that the three toxin components might act synergistically in vivo to cause lethality and edema formation.
Bacillus anthracis, the etiological agent of anthrax is a gram-positive bacterial pathogen of humans and animals. It secretes two toxins, the edema and lethal toxins, made up of three different proteins, protective antigen (PA; 85 kDa), lethal factor (LF; 83 kDa), and edema factor (EF; 89 kDa) (8, 18, 28) . Both toxins are organized according to the A-B-type model, in which a B domain involved in cellular receptor binding is associated with an A domain displaying toxic and usually enzymatic activities (10) . In the case of anthrax toxins, the A and B domains are two separate proteins. The PA factor is the B component in both the edema and lethal toxins. PA is the receptor-binding component mediating entry of either LF or EF into target cells (17) . EF has been shown to be a calmodulin-dependent adenylate cyclase (16) . No enzymatic activity has yet been identified for LF. Consistent with the A-B model, none of the three individual proteins is toxic for animals (27) . However, PA combined with LF forms the lethal toxin, whose intravenous injection leads to death in experimental animals (3, 27) . Edema toxin consists of PA and EF. It induces an increase in intracellular cyclic-AMP levels in eukaryotic cells (16) and elicits skin edema after subcutaneous injection (7) .
Fully virulent strains of B. anthracis are encapsulated and toxigenic. Formation of the capsule, a poly-D-glutamic acid polymer (2) , is dependent on the presence of plasmid pXO2 (11, 34) . The toxin production is conferred by plasmid pXO1 (21) , which carries the structural genes encoding PA, EF, and LF. These three genes, respectively pag, cya, and lef, have been cloned and sequenced (4, 6, 21, 38) , thus providing the basis for genetic studies.
The pathogenesis of infection by B. anthracis, the role of the two toxins in the disease, and the molecular mechanism of the lethal effect of the toxins remain poorly understood. Most of the available data have been obtained with purified * Corresponding author. toxin components (3, 7, 27) or by studying animal susceptibility to B. anthracis strains (35, 37) . The Sterne strain has been widely used in animal models. This unencapsulated strain, carrying only plasmid pXO1, is toxigenic and is used as a live veterinary vaccine against anthrax (12, 29, 36) . Nevertheless, the inoculation of mice with high doses of Sterne strain spores causes a lethal disease that seems to be identical to anthrax caused by a fully virulent encapsulated B. anthracis strain (35) . The pathogenesis of infection with the Sterne strain is the result of the effects of the three components (PA, EF, and LF) produced by this strain. This paper describes an analysis of the role of individual toxin components accomplished by inactivating each toxin gene encoded by pXO1.
As previously reported (31), a conjugal transfer system which can be used to transfer DNA into B. anthracis is available. We devised a genetic strategy allowing the construction of a mutant strain deficient in PA (5) but producing normal amounts of LF and EF. In the present work, the strategy has been extended to the genes encoding EF and LF. We obtained and characterized Sterne strain mutants producing only one toxin: either lethal toxin (PA+LF) or edema toxin (PA+EF). Analysis of the virulence of these mutants in the mouse provides new insights into the contribution of each toxin to the pathogenesis of B. anthracis.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture media. Escherichia coli HB101 harboring the mobilizing plasmid pRK212.1 (31) (22) , and B. anthracis was grown in brain-heart infusion medium (Difco Laboratories, (26) and derived from a 9-kb SacI DNA fragment was cloned into pUC18 (39) and pAT18 (32) . Mating procedure. The recombinant shuttle plasmids were transferred from E. coli to B. anthracis 7702 by conjugation. The filter mating system was used as previously described (5, 31) . E. coli and B. anthracis were grown in L and brain heart infusion media, respectively: S x 108 E. coli and 1 x 108 B. anthracis cells were mixed, washed to eliminate antibiotics, and loaded onto a Millipore 0.45-p.m-pore-size filter supported on brain heart infusion agar. After 15 h of incubation at 37°C, cells were resuspended and plated on selective media containing appropriate antibiotics.
Adenylate cyclase assay. Adenylate cyclase was assayed in B. anthracis R-medium culture supernatants as previously described (14) . Enzymatic activity is expressed in units per milliliter. One unit corresponds to 1 nM cyclic AMP formed in 1 min at 30°C.
Protein analysis. Sodium dodecyl sulfate-polyacrylamide (8%) gel electrophoresis was performed as described by Laemmli (15) . Gels were either stained with Coomassie blue or subjected to immunoblot analysis (30) . Western blots (immunoblots) were probed with rabbit sera raised against LF or PA purified from the polyacrylamide gel or against a truncated form of EF (CYA62) (13) . Immunodetected proteins were visualized with '25I-labeled protein A and autoradiography on X-ray films.
Preparation of spores. Stocks of B. anthracis strains were prepared as follows. Bacteria were streaked on NBY agar slopes and incubated for 7 days at 30°C. Spore formation was monitored by phase microscopy. Five milliliters of sterile distilled water was added to each slope, and the samples were suspended. The spore suspension, in a sterile screwcap tube, was incubated at 65°C in a water bath for 30 min to kill any remaining bacilli. The spores were collected by centrifugation and resuspended in water (1/20 [vol/vol] of the original culture) to give samples containing at least 90% spores and 108 CFU/ml. These spore stocks were divided into 5-ml aliquots and stored at 4°C. Prior to each infection in mice, aliquots were diluted and viable spore counts were estimated. Spores of B. subtilis were obtained in L broth after incubation of bacteria for 17 h at 37°C and were prepared according to the same procedure.
Infection of mice. Female 3-to 6-week-old pathogen-free Swiss mice were supplied by Charles River (Saint-Aubin-lezElboeuf, France). Animals were fed a sterilized vitaminsupplemented diet and sterile water (pH 3). Mortality was monitored by subcutaneously inoculating groups of 10 mice with appropriate viable spore doses (in a volume of 0.2 ml).
The 50%o lethal dose (LD50) was determined for groups of 10 mice by the probit method (1). Bacterial survival in host tissues was monitored by infecting mice in the right hind footpad with large doses of spore suspensions (in a volume of 0.1 ml). The magnitude of the inflammatory reaction induced in the infected footpad was measured at intervals with dial callipers (Schnelltaster, Hessen, Federal Republic of Germany) and compared with the size of the contralateral noninfected footpad. The results are expressed in units (0.1 mm) of footpad thickness. Groups of five infected mice were sacrificed at intervals, and feet were sectioned, washed with sodium hypochlorite solution (1 min) to kill skin contaminants and then with sterile phosphate-buffered saline (pH 7.2) (1 min), and ground in phosphate-buffered saline. One hundred microliters of serial 10-fold dilutions in phosphatebuffered saline were plated on brain heart infusion agar.
Results were expressed as the log1o bacterial count per foot.
RESULTS

Construction and characterization of B. anthracis EF-or
LF-strains. A genetic strategy has previously been devised and used for the construction of a B. anthracis strain, RP8, deficient for PA (5) . A similar strategy was used for the inactivation of the lefand cya genes on pXO1, which encode LF and EF, respectively. The details of the constructions are given in Fig. 1 . The first step was performed in E. coli. Deletions removing part of cya and lef were followed by insertion of a kanamycin resistance cassette (33 cloned into pAT18 (32) . The resulting recombinant shuttle plasmid pCPL110 (lefA238) or pMMA110 (cyaA303) was transferred by conjugation into B. anthracis 7702, yielding Ermr Kanr transconjugants which harboured both pXO1 and one recombinant plasmid (pCPL110 or pMMA110). These transconjugants were cultured in the absence of erythromycin (selective antibiotic for pMMA11O or pCPL110) but in the presence of kanamycin (selecting for the maintenance of the cassette). Kanr Erms clones which presumably had lost the recombinant plasmid and integrated the Kanr cassette into pXO1 by homologous recombination were isolated (5). Two clones called RP9 and RP10, which originated from transconjugants carrying pMMA110 or pCPL110, respectively, were thus obtained and used for subsequent experiments.
For both strains, replacement of the wild-type lef or cya gene on pXO1 by the corresponding deleted copy carrying the Kanr cassette was verified. In plasmid pXO1, the lefgene is located on a 9-kb Sacl fragment (26) and the cya gene is located on a 7-kb BamHI fragment (6, 23) . BamHI or Sacl digests of recombinant pXO1 plasmids originating from strains RP9 and RP10, respectively, were cloned into pUC19. Recombinant pUC derivative plasmids, able to confer Kanr on E. coli, were obtained in both cases. Restriction enzyme analysis of these plasmids indicated that they contained DNA fragments carrying the expected constructions (Fig. 1) . These results therefore confirmed that the inactived genes cyaA303 and lefA238 were present on pXO1, yielding EF-(RP9) and LF-(RP1O) strains.
Toxin production in mutant strains of B. anthracis. The three anthrax toxin components PA, EF, and LF are produced by B. anthracis 7702 when bacteria are grown in R medium (25) . These three proteins were easily detected in supernatants by Western blot analysis with specific antisera raised against EF, LF, or PA (Fig. 2, 7702) . EF has adenylate cyclase activity. The adenylate cyclase activity in the supernatants of cultures of the EF-strain and parental strain 7702 was therefore determined. In EF-strain supernatants, no adenylate cyclase activity was found, whereas in strain 7702 supernatants, 200 U of activity per ml was found. Consistently, supernatants of RP9 cultures contained no EF-related protein, as determined by Western blot analysis (Fig. 2, EF-, lane A) , thus confirming the inactivation of the cya gene in this strain. No LF-related protein was detected by Western blot of supernatants of RP10 cultures (Fig. 2, LF-, lane B), but the adenylate cyclase activity was identical to that of strain 7702 (200 U/ml). As previously described (5), PA-mutant RP8 was deficient in the production of PA (Fig. 2 , PA-, lane C) but still produced adenylate cyclase (300 U/ml) and LF in supernatants. These results clearly show that each of the three mutants, PA-, EF-, and LF-, are specifically defective for the production of only one toxin component and can therefore be used in an experimental model to study the contribution of these proteins to the pathogenesis of B. anthracis infection.
Virulence of B. anthracis mutants in mice. The virulence of the three B. anthracis mutants was studied in mice by using parental strain 7702, pXO1-free strain 7700, and an unrelated avirulent B. subtilis strain, SMY, as controls. The LD50 of each strain was first estimated by subcutaneously inoculating groups of 10 mice with a series of doses of spores (104 to 109) from these strains, and mortality was monitored for 15 days. The results are reported in Table 2 . Parental strain 7702, which produces the three toxin components, induced a rapidly lethal infection (3 to 4 days). The LD50 was estimated to be 106 spores per mouse. As expected, pXO1-free strain 7700, the PA-mutant, and B. subtilis were totally avirulent, with a LD50 of >10' spores. The LF-mutant totally abolished the lethality of B. anthracis regardless of the production of adenylate cyclase (EF). In contrast, the EFmutant caused mortality in mice within 3 to 4 days. The estimated LD50 was 107 spores, which is 1 log1o unit higher than that of the wild type. These results clearly indicate that adenylate cyclase contributes to the expression of virulence in mice.
The magnitude of the inflammatory reaction elicited by the various strains was then estimated by inoculating spores intradermally into the right hind footpads of mice. The kinetics of footpad edema was monitored with a dial calliper. The results are illustrated in Fig. 3 . The inoculation of 108 spores induced a rapid swelling (13 to 22 U, with 1 U corresponding to 0.1 mm) after 6 h. The subsequent kinetics of the inflammatory reaction was dependent on the virulence factors expressed by the strains. Strain 7700 and EF-and PA-mutants behaved similarly in that they produced a weak inflammatory reaction. Strain 7702 and LF-mutants induced edema formation that reached a peak of 30 to 40 U after 24 to 48 h. This strong inflammatory reaction further persisted only with strain 7702. As shown in Fig. 3B and C, edema formation was dose dependent, with almost no effect from an inoculum of 106 spores. To determine the effect of differential local bacterial survival in host tissues on the inflammatory reaction, bacteria were counted in the footpads of mice inoculated with high challenges (108 spores). As shown on Fig. 4 , bacterial growth curves were remarkably similar for all strains of B. anthracis, with a long-lasting plateau of around 108 bacteria per footpad for 5 days. B. subtilis wild-type strain SMY was eliminated from host tissues, with a 3-log decrease by day 5 of infection (Fig. 4) . These data indicate that the differences observed in the magnitudes of inflammatory reactions caused by B. anthracis mutants are not related to the survival of bacteria in the footpads but presumably to the local production of toxins. That all strains of B. anthracis, including 7700, survived significantly longer than B. subtilis in the mouse means that bacterial survival is not related to toxin production but might be due to intrinsic properties of B. anthracis.
DISCUSSION
In this work, we constructed and studied B. anthracis mutant strains derived from the parental toxigenic 7702 Sterne strain and producing both lethal (PA+ LF) and edema (PA+EF) toxins. EF-and LF-mutants were obtained by well-characterized deletions within the cya and lef genes, respectively. In both mutants, the mutations appear to abolish gene expression, since no truncated gene products (Fig. 2) mutations, which were introduced into pXO1 by exchanging the wild-type pag, cya, and lef genes with their mutated alleles. The mutant strains are therefore specifically deficient for PA, EF, and LF, and as a consequence of the procedure used, reversion to wild type cannot occur. The precise genetic characterization and the stability of these strains make them highly reliable for pathophysiological studies. The virulence of these three well-defined mutants was then studied in mice by assessing two parameters characteristic of anthrax: lethality and local edema. The results of LD50 determinations for the different strains ( Table 2 ) strongly suggest that LF in combination with PA is the key virulence factor of B. anthracis: the production of LF is absolutely required for lethal infection ( Table 2 ). Skin edema formation can unambiguously be attributed to edema toxin (PA+EF) expression on the basis of the kinetics of the inflammatory responses produced in the footpads by the various strains (Fig. 3) . Our results are also consistent with previous reports showing that PA is needed for the toxic effects of EF and LF (5, 17) , since the PA-mutant (RP8) failed to induce either edema or a lethal infection in mice.
EF-and LF-mutants were significantly less efficient at inducing lethality and edema than the Sterne strain. It appears, therefore, that adenylate cyclase also plays a role during lethal infection. Twenty-four years ago, Smith and Stoner (27) reported that the three toxin components together were more lethal and caused more serious edemas than either PA+LF or PA+EF. Although these data were obtained with proteins presumably difficult to purify from each other, our data fully confirm this finding. It is possible that lethal and edema toxins are synergistic and can cooperate at the cellular level or modify the interaction of bacteria with the host.
However, the mechanisms whereby lethal factor and adenylate cyclase of B. anthracis act as virulence factors during lethal infection are not understood. Purified PA+LF exhibits a lytic effect on macrophages in vitro (9) , but the mode of action and the target cells of LF remain unknown. It has been proposed that B. anthracis adenylate cyclase might inhibit phagocytosis of polymorphonuclear neutrophils (24), as described for Bordetella pertussis adenylate cyclase (20) . Nevertheless, EF+ strains did not appear to survive longer in the host than EF-strains. Surprisingly, we found in this study that the survival of all the strains of B. anthracis at the inoculum site was similar during the initial period of infection regardless of the expression of toxins (Fig. 4) . This means that pXO1-encoded virulence factors play a minor role, if any, in local bacterial survival. They are presumably involved in the lethal effect and in bacterial dissemination from the inoculum site. This finding also implies that there are as-yet-unidentified chromosomal genes required for survival in host tissues. This study provides the first in vivo analysis of the role of each toxin component in the pathogenesis of B. anthracis infection. These results are in agreement with those obtained with purified toxin components injected into animals (3, 7, 27) and with recent data from cell tissue cultures (9, 16, 24) which have been used to construct models for anthrax toxin action (17) . The mutant strains described in this work will be powerful tools for investigations of the role of these toxins during the process of infection. Further studies will also indicate whether these strains could be valuable as live vaccines against anthrax.
